Here are five things to know:
1. Nine ratings firms covering AmSurg stock provided the “buy ” rating.
2. Christopher Holden, CEO of AmSurg, sold 3,000 shares of stock on June 3.
3. Shares were sold at an average price of $60.09 for a total transaction worth $207,060.
4. AmSurg shares traded up 0.23 percent last Thursday, reaching $70.36.
5. The stock has a 50-day moving average of $69.27 and a 200-day moving average of $61.66. The market cap is $3.35 billion.
For more ASC news:
38 spine-driven ASCs to know | 2015
Go beyond analytics: How business intelligence can make ASCs more money (Part 2)
Opportunities during times of change: Key strategies for orthopedic centers
